Skip to main content
OpenTrials

Clinical trial condition

Generalized Myasthenia Gravis

Explore clinical trials studying Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Generalized Myasthenia Gravis trial results

Active, not recruiting

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

NCT05070858

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology 2018 Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
  • University of Southern California Los Angeles, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
View all 116 locations
View Trial Details
Active, not recruiting

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

NCT05556096

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Research Site Orange, California, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Bradenton, Florida, United States
View all 132 locations
View Trial Details
Active, not recruiting

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

NCT05644561

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Chapel Hill, North Carolina, United States
  • Research Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

NCT04650854

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0007 50092 Orange, California, United States
  • Mg0007 50099 San Francisco, California, United States
  • Mg0007 50122 Miami, Florida, United States
  • Mg0007 50120 Miami, Florida, United States
View all 69 locations
View Trial Details
Completed

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT04124965

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0004 50081 Phoenix, Arizona, United States
  • Mg0004 50072 Los Angeles, California, United States
  • Mg0004 50088 Washington D.C., District of Columbia, United States
  • Mg0004 50120 Miami, Florida, United States
View all 43 locations
View Trial Details
Completed

A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT03971422

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0003 50081 Phoenix, Arizona, United States
  • Mg0003 50082 Scottsdale, Arizona, United States
  • Mg0003 50072 Los Angeles, California, United States
  • Mg0003 50092 Orange, California, United States
View all 112 locations
View Trial Details
Completed

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0011 41 Mobile, Alabama, United States
  • Mg0011 116 Phoenix, Arizona, United States
  • Mg0011 31 Irvine, California, United States
  • MG0011 4 Los Angeles, California, United States
View all 70 locations
View Trial Details
Completed

An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis

NCT04980495

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +13 more
Locations
  • Investigator Site 10 - US0010007 Carlsbad, California, United States
  • Investigator Site 7 - US0010001 Orange, California, United States
  • Investigator Site 9 - 0010006 Boca Raton, Florida, United States
  • Investigator Site 15 - US0010014 Coral Springs, Florida, United States
View all 39 locations
View Trial Details
Completed

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

NCT06471361

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Dv0013 50628 New Haven, Connecticut, United States
  • Dv0013 50634 Tampa, Florida, United States
  • Dv0013 50648 Columbia, Missouri, United States
  • Dv0013 50556 Chapel Hill, North Carolina, United States
View Trial Details
Completed

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

NCT04818671

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator site 6 - US0010032 Carlsbad, California, United States
  • Investigator Site 47 - US0010021 Palo Alto, California, United States
  • Investigator Site 45 - US0010108 Boca Raton, Florida, United States
  • Investigator site 4 - US0010110 Port Charlotte, Florida, United States
View all 47 locations
View Trial Details

Related conditions